Global Favipiravir Market is expected to grow at a CAGR of 4.8% from 2020 to 2027
Favipiravir functions as a prodrug which undergoes ribosylation and phosphorylation to get converted into the active favipiravir-RTP which inhibits RNA dependent RNA polymerase to prevent the transcription and replication of the viral genome. Influenza is currently representing the largest market share in the treatment segment for favipiravir market. As per the latest statistics provided by […]
Global Favipiravir Market is expected to grow at a CAGR of 4.8% from 2020 to 2027 Read More »